BIONXT SOLUTIONS INC. (BXT) - Total Liabilities

Latest as of March 2026: €7.65 Million EUR ≈ $8.94 Million USD

Based on the latest financial reports, BIONXT SOLUTIONS INC. (BXT) has total liabilities worth €7.65 Million EUR (≈ $8.94 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See BIONXT SOLUTIONS INC. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

BIONXT SOLUTIONS INC. - Total Liabilities Trend (2021–2025)

This chart illustrates how BIONXT SOLUTIONS INC.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see BIONXT SOLUTIONS INC. balance sheet assets.

BIONXT SOLUTIONS INC. Competitors by Total Liabilities

The table below lists competitors of BIONXT SOLUTIONS INC. ranked by their total liabilities.

Company	Country	Total Liabilities
Ntaw Holdings Ltd AU:NTD	Australia	AU$240.37 Million
Kyobo 3 SPAC KQ:208710	Korea	₩41.78 Billion
Optimi Health Corp. Common Shares NASDAQ:OPTH	USA	$5.79 Million
Ram Technology Co. Ltd KQ:171010	Korea	₩68.89 Billion
Hunyvers SA PA:ALHUN	France	€75.34 Million
Aetherium Acquisition Corp NASDAQ:GMFI	USA	$10.13 Million
Eqva ASA OL:EQVA	Norway	Nkr888.00 Million
Ropharma Bras RO:RPH	Romania	RON688.42 Million

Liability Composition Analysis (2021–2025)

This chart breaks down BIONXT SOLUTIONS INC.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See BIONXT SOLUTIONS INC. balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.01	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	22.92	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BIONXT SOLUTIONS INC.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BIONXT SOLUTIONS INC. (2021–2025)

The table below shows the annual total liabilities of BIONXT SOLUTIONS INC. from 2021 to 2025.

Year	Total Liabilities	Change
2025-12-31	€9.96 Million ≈ $11.64 Million	+18.11%
2024-12-31	€8.43 Million ≈ $9.86 Million	+28.71%
2023-12-31	€6.55 Million ≈ $7.66 Million	+14.10%
2022-12-31	€5.74 Million ≈ $6.71 Million	-28.75%
2021-12-31	€8.06 Million ≈ $9.42 Million	--

About BIONXT SOLUTIONS INC.

F:BXT Germany Drug Manufacturers - Specialty & Generic

Market Cap

$31.34 Million

€26.80 Million EUR

Market Cap Rank

#24492 Global

#2109 in Germany

Share Price

€0.20

Change (1 day)

+2.07%

52-Week Range

€0.17 - €0.57

All Time High

€2.28